Incyte Corporation
INCY
$98.07
-$1.97-1.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.84% | 20.05% | 16.46% | 19.53% | 16.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.84% | 20.05% | 16.46% | 19.53% | 16.32% |
| Cost of Revenue | 29.47% | -8.13% | -52.34% | 4.73% | 9.41% |
| Gross Profit | 26.34% | 58.84% | 501.27% | 35.15% | 23.52% |
| SG&A Expenses | 12.52% | 6.42% | 15.80% | 8.50% | 17.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.04% | -3.49% | -39.29% | 5.93% | 12.48% |
| Operating Income | 44.22% | 153.83% | 170.00% | 135.87% | 31.65% |
| Income Before Tax | 24.29% | 208.14% | 243.16% | -0.83% | 15.78% |
| Income Tax Expenses | -19.42% | 16.12% | 179.10% | 14.08% | 61.01% |
| Earnings from Continuing Operations | 48.74% | 298.45% | 191.09% | -6.69% | 0.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 48.74% | 298.45% | 191.09% | -6.69% | 0.07% |
| EBIT | 44.22% | 153.83% | 170.00% | 135.87% | 31.65% |
| EBITDA | 41.18% | 136.64% | 179.06% | 110.11% | 27.04% |
| EPS Basic | 45.51% | 292.29% | 202.45% | 8.13% | 16.16% |
| Normalized Basic EPS | 42.39% | 135.53% | 197.17% | 110.93% | 32.86% |
| EPS Diluted | 43.63% | 290.74% | 200.00% | 6.67% | 14.32% |
| Normalized Diluted EPS | 40.33% | 132.60% | 194.84% | 108.68% | 31.09% |
| Average Basic Shares Outstanding | 2.22% | 1.58% | -11.08% | -13.71% | -13.86% |
| Average Diluted Shares Outstanding | 3.72% | 2.85% | -8.91% | -12.77% | -12.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |